VIVO Insider Trading Activity and SEC Form 4 Filings
VIVO insider trading summary
No open-market insider purchases or sales of Meridian Bioscience Inc (VIVO) have been reported on SEC Form 4 in the past 12 months.
Latest VIVO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 27, 2022 | John P. Kenny | Chief Executive Officer | Sell | $1.9M (61,437 @ $30.39) |
| Jun 24, 2022 | John P. Kenny | Chief Executive Officer | Sell | $407K (13,559 @ $30.00) |
| Jun 23, 2022 | John P. Kenny | Chief Executive Officer | Sell | $598K (19,956 @ $29.98) |
| Jun 22, 2022 | John P. Kenny | Chief Executive Officer | Sell | $1.3M (44,651 @ $29.72) |
| Feb 25, 2022 | Andrew S. Kitzmiller | EVP & CFO | Buy | $100K (4,028 @ $24.87) |
| Feb 15, 2022 | Lourdes Weltzien | EVP, Life Science | Sell | $512K (20,000 @ $25.60) |
| Mar 17, 2021 | John P. Kenny | Chief Executive Officer | Sell | $750K (30,000 @ $25.00) |
| Mar 10, 2021 | John P. Kenny | Chief Executive Officer | Sell | $250K (10,000 @ $25.00) |
| Feb 16, 2021 | John P. Kenny | Chief Executive Officer | Sell | $72K (2,359 @ $30.35) |
| Feb 12, 2021 | John P. Kenny | Chief Executive Officer | Sell | $789K (26,181 @ $30.14) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.